Ultrafast 30‐min infusion of a rituximab biosimilar (Truxima)-Reference-Cited by-同舟云学术

Ultrafast 30‐min infusion of a rituximab biosimilar (Truxima)

Published:2023-10-17 Issue:4 Volume:4 Page:1196-1199
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Pérez‐Persona Ernesto¹^ORCID,Cuevas Palomares Laida²³,Unamunzaga Cilaurren Ariane²,Gutiérrez López de Ocáriz Xabier²,Buendía Ureña Buenaventura²,Vega González de Viñaspre Ana²,Benito Ibarrondo Begoña⁴,Molinillo Fernández María Carmen⁴,Cordero Osúa Ana⁴,Benítez Delgado Beatriz⁴,García Albás Juan José⁵,Andrés Moralejo Miguel Ángel⁵,Guinea de Castro José María²

Affiliation:

1. Department of Haematology Complejo Hospitalario de Navarra Pamplona Spain

2. Bioaraba (Onco‐Haematology Group) Vitoria‐Gasteiz Spain

3. Osakidetza (OSI Araba) Hospital Universitario de Álava (Department of Haematology) Vitoria‐Gasteiz Spain

4. Osakidetza (OSI Araba) Hospital Universitario de Álava (Day‐care Unit) Vitoria‐Gasteiz Spain

5. Osakidetza (OSI Araba) Hospital Universitario de Álava (Department of Pharmacy) Vitoria‐Gasteiz Spain

Abstract

AbstractIn this clinical trial, we demonstrate that ultrarapid fast infusion of rituximab (Truxima) in 30 min with oral premedication is feasible and secure for patients, and reduce the day‐care hospital stays.

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.812

Reference14 articles.

1. CHMP. ANNEX I summary of product characteristics

2. Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma

3. A Phase I-II Study to Determine the Maximum Tolerated Infusion Rate of Rituximab with Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function

4. Sixty-minute infusion rituximab protocol allows for safe and efficient workflow

5. Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid rituximab administration: Safety of 60-minute infusions in malignant and benign haematological disease;Journal of Oncology Pharmacy Practice;2024-06-07